FEEDBACK PLC — AGM Information 2020

Nov 6, 2020

National Storage Mechanism | Additional information

RNS Number : 5643E

Feedback PLC

06 November 2020

The following amendments have been made to the 'Result of Annual General Meeting' announcement released on 5 November 2020 at 1.23 pm under RNS No 4187E.

The 'Total Votes Cast' column in the table below has been updated to show the correct figures. All other details remain unchanged. The full amended text is shown below.

Feedback plc

Result of Annual General Meeting - Amendment

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that at its annual general meeting held earlier today, all resolutions were duly passed on a poll. The proxy voting results of the resolutions are included below.

Resolutions	Votes For*	% of votes cast**	Votes Against	% of votes cast**	Votes Withheld**	Total votes cast**
1. To receive and adopt the annual report and accounts for the year ended 31 May 2020	504,134,927	100.00%	-	0.00%	22,000	504,134,927
2. To elect Adam Denning as a director	504,152,622	100.00%	3,305	0.00%	1,000	504,155,927
3. To elect Philipp Prince as a director	479,902,622	95.19%	24,253,305	4.81%	1,000	504,155,927
4. To re-elect Simon Sturge as a director	504,152,486	100.00%	3,441	0.00%	1,000	504,155,927
5. To appoint Price Bailey LLP as auditors of the Company	504,118,963	99.99%	36,964	0.01%	1,000	504,155,927
6. To authorise the directors to allot relevant securities equivalent to up to two thirds of the Company's issued share capital, subject to certain conditions	504,027,372	100.00%	3,305	0.00%	126,250	504,030,677
7. To authorise the directors to allot relevant securities equivalent to up to 10 per cent. of the Company's issued share capital on a non-pre-emptive basis subject to certain conditions	478,945,731	95.01%	25,135,091	4.99%	76,205	504,080,822

Notes:

* "Votes For" include votes giving the Chairman discretion.

** "Votes Withheld" are not votes in law and do not count in the number of votes counted for or against a resolution, or towards the total votes cast.

-Ends-

Enquiries:

Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO	+44 (0)1954 718072 IR@fbk.com
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai	+44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey	+44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes	+44 20 3815 8880
Walbrook PR Ltd	Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas Johnson	07980 541 893 or 07748 325 236 or 07884 664 686

Notes to Editors

Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go. 

Its highly scalable Software as a Service ("SaaS")-based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGGZMGMKVGGGZM